All News

Dr Naovarat reports on 18 year outcomes of HIV and rheumatic disease. 16 patients treated with TNFi, including 2 who switched to tocilizumab and ustekinumab. No major infections. Rising viral load in 1 led to discontinue. Abstr#0965 #ACR21 @RheumNow https://t.co/jcGPaURKmb
Richard Conway RichardPAConway ( View Tweet)
#ACR21 #Rheumatology #Pearl: In #Takayasu's, listen for bruits on the back- could be originating from pulmonary artery or descending aorta. @RheumNow https://t.co/0wGdR3Rqy2
Mrinalini Dey DrMiniDey ( View Tweet)
Supplementation for 5 years with vitamin D3 +/- n-3 fatty acids reduced incident autoimmune disease by 25-30% in older adults vs. those who received neither supplement. The effect of vitamin D3 appeared stronger after 2 years @RheumNow #ACR21 Abst#0957 https://t.co/uOwNyjxEoG https://t.co/S5kIM4kj6L

Links:

Dr. Antoni Chan synovialjoints ( View Tweet)
Don't stop hydroxychloroquine in SLE, even when doing well. Associated with ⬆️flare risk. x2 even when in remission. Abstr#0959 #ACR21 @RheumNow https://t.co/1gGx0V5oxk
Richard Conway RichardPAConway ( View Tweet)
1133 MACE events in Oral Surveillance study - Tofa use in high risk pts had more MACE events than TNFi use. Abstr# 0958 #ACR21 Problems with the gimmish are: - Older patients, w/ Hi CV Risk - 50% prednisone use - Use of TNFi as comparator (effective at lowering CV risk) https://t.co/lzIyhgzvRe
Dr. John Cush RheumNow ( View Tweet)
The strawberry🍓gums of granulomatosis with polyangiitis! (Note: not always so florid) @RheumNow #ACR21 #RheumTwitter #MedTwitter https://t.co/qDfGJ5JeWz
sheila RHEUMarampa ( View Tweet)
⭐️IR for MACE, MI, non-fatal MI numerically ⬆️ in Tofa vs. TNFi ⭐️HR for MACE/MI/stroke >1 for Tofa vs. TNFi ⭐️Risk factors: Smoking, ASA use, Age>65, men ⭐️Pts without risk factors, IR for MACE were similar Abs#958 #ACR21 @RheumNow #ACRBest https://t.co/xA3aGu5Sqi https://t.co/VnPHBhrmdx

Links:

Robert B Chao, MD doctorRBC ( View Tweet)
okay, so let's look at the #ACR21 plenary as we go so a reminder - FDA-mandated phase 3b/4 safety endpoint study specifically looking at patients >50yo with at least one other CV risk factor today we're looking at MACE: that's CV death (excl PE), MI, stroke ABST0958 @RheumNow https://t.co/9U8Sahb9Q7
David Liew drdavidliew ( View Tweet)
Vitamin D ⬇️incident autoimmune diseases & so do fatty acids but latter is not stat signif. 25k older adults with factorial design, no interaction. ? Buy vit D stock @RheumNow #ACR21 #ACRBest VITAL trial abst#0957 https://t.co/Qk3VwNOZie
Janet Pope Janetbirdope ( View Tweet)
Can vit D, omega-3 fatty acids prevent autoimmune dx development, even in non-deficient people? (some plausibility, no other meds can) vit D *might* have an effect, esp post-2y cautious interest seems okay! extension worth looking at VITAL trial add-on #ACR21 ABST0957 @RheumNow https://t.co/H5aF8Vl79u
David Liew drdavidliew ( View Tweet)
Can vit D and omega3 prevent autoimmune dz? 25,871 adult pts randomized:vit D 2000 IU daily, omega 3 (1 g/d), combo, PCB and followed 5 yrs Vit D & combo showed statistical sig over time, omega3 showed a favorable trend Abst#0957 #Plenary #ACRbest @rheumnow https://t.co/moMCm9IJmO
TheDaoIndex KDAO2011 ( View Tweet)
Take your supplements 🐠 fish oil and Vit D! VITAL RCT presented by @karen_kc123 shows Vit D +/-n-3 fatty acid ⬇️ incidence of AID compared to PBO. Promising although AID were self reported! @RheumNow #ACR21 #Abst0957 https://t.co/xdEdKuwXci #ACRBest https://t.co/zWrr9oC7F5

Links:

Aurelie Najm AurelieRheumo ( View Tweet)
Interesting study with Dr. Julia Manasson on gut and skin microbiome in monozygotic twins discordant for psoriatic disease. (red = Psoriatic). Gut ruminococcus bromii virtually absent in psoriatic pts. Eager to see further studies! #ACR21 Abst#0944 @RheumNow https://t.co/zrZPBAjh5p
Pedro Castillo _Castillo_Pedro ( View Tweet)
Clinical Pearl at @ACR21 Is patchy tongue erythema + angular chelitis representative of Sjogren's or oral candidiasis? Beware: Oral candiasis is a mimic of Sjogren's tongue. Differentiate by asking if burning of tongue. If so, not Sjogren's -- start PO antifungal! @RheumNow https://t.co/FbdiX8PFKV
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
I honestly find Vit D literature confusing! VITAL RCT omega3 and vit D in preventing autoimmune diseases. They seems to work?🧐The confidence intervals just shy of 1.00...I am still skeptical..but keeping vit D normal doesnt hurt I guess....#ACR21 @rheumnow abst#0957 https://t.co/QFcz2zK4Ic
Bella Mehta bella_mehta ( View Tweet)
Physician global score was the strongest predictor of future flares in AS patients with TNFi dose tapering. 29 (27%) flared at 2/3 of standard dose, 21 (20%) at 1/2 dose, 29 (27%) at 1/3 dose and 27 (25%) after discontinuation @RheumNow #ACR21 Abst#0929 https://t.co/pIzLgexe3k https://t.co/UM9cGLiYl7

Links:

Dr. Antoni Chan synovialjoints ( View Tweet)
Abst#0946 shows a distinct lipid profile in RA vs PsA synovium + synovial fluid. Sphingomyelins & phosphatidyl-cholines/ethanolamines had the greatest separation power to classify RA + PsA samples. These lipid markers may have clinical utility if validated. #ACR21 @Rheumnow https://t.co/ktKRypTtlE
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
SKIPPAIN results: Spinal pain response after 8 weeks of SEC showed notable differences between HLA-B27 subgroups. Can subtype pre-determine tx efficacy/response? Abs 0917 #ACR21 #RheumNow @RheumNow https://t.co/FKpCqXpobM https://t.co/WbjjyTIaiG

Links:

Dr. Rachel Tate uptoTate ( View Tweet)
MCP, wrist, elbow, shoulder and ankle: Not common sites for #osteoarthritis so consider a metabolic disease like CPPD🧐 @RheumNow #ACR21 #RheumTwitter #MedTwitter https://t.co/utId4ljsZK
sheila RHEUMarampa ( View Tweet)
IV Golimumab efficacy and Early (ED) vs Late (LD) AS ⭐️ED better response than LD with PRO ⭐️Treatment-emergent adverse events/ serious adverse 🔼 LD as compared to ED Abst #0912 #ACR21 @RheumNow https://t.co/5EaWAvfQ57
swethaann23 swethaann23 ( View Tweet)
×